• RheinCell Therapeutics Achieves GMP Certification contractpharma
    January 15, 2021
    ​RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization.
PharmaSources Customer Service